Yi-Yang Hu
Overview
Explore the profile of Yi-Yang Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Yao D, Xu L, Yan D, Zhao Y, Peng J, et al.
Curr Med Sci
. 2024 Dec;
44(6):1241-1248.
PMID: 39617866
Objective: Jianpi huoxue decoction (JHD), a Chinese herbal formula, is commonly used for treating alcohol-associated liver disease (ALD). This study aimed to investigate the mechanism by which JHD affects intestinal...
2.
Hu Y, Liao H, Yuan L, Deng Y
Environ Monit Assess
. 2024 Nov;
196(12):1240.
PMID: 39579256
The concentration of PM2.5 is one of the air quality indicators that the public pays the most attention to. Existing methods for PM2.5 prediction primarily analyze and forecast data from...
3.
Lin R, Sun Q, Xin X, Ng C, Valenti L, Hu Y, et al.
Metabolism
. 2024 Oct;
161:156043.
PMID: 39357599
Aims: To compare the efficacy of thyroid hormone receptor beta (THR-β) agonists, fibroblast growth factor 21 (FGF-21) analogues, glucagon-like peptide-1 receptor agonists (GLP-1RAs), GLP-1-based polyagonists, and pan-peroxisome proliferator-activated receptor (Pan-PPAR)...
4.
Bai C, Ren J, Zhang X, Hu Y, Wang X, Tang X, et al.
Heliyon
. 2024 Feb;
10(3):e25791.
PMID: 38356534
Introduction: Acute-on-chronic liver failure (ACLF) is a clinical syndrome with high short-term mortality. ACLF has been increasingly studied in recent years; however, a bibliometric analysis of the entire ACLF field...
5.
An Z, Liu Q, Ye X, Zhang Q, Pei H, Xin X, et al.
Clin Transl Gastroenterol
. 2024 Jan;
15(3):e00680.
PMID: 38240390
Introduction: In metabolic dysfunction-associated steatotic liver disease, the diagnostic efficacy of controlled attenuation parameter (CAP) was not very accurate in evaluating liver fat content. The aim of this study was...
6.
Gao S, Xin X, Wang Z, Hu Y, Feng Q
Mol Cell Probes
. 2023 Dec;
73:101944.
PMID: 38049041
Ubiquitin specific protease 5 (USP5) is a vital deubiquitinating enzyme that regulates various physiological functions by removing ubiquitin chains from target proteins. This review provides an overview of the structural...
7.
Liang S, Li P, Hu Y, Zhao J, Shao F, Kuang F, et al.
Front Immunol
. 2023 Sep;
14:1193081.
PMID: 37680624
Yolk sac-derived microglia and peripheral monocyte-derived macrophages play a key role during Parkinson's disease (PD) progression. However, the regulatory mechanism of microglia/macrophage activation and function in PD pathogenesis remains unclear....
8.
Zhang Q, Jin Y, Xin X, An Z, Hu Y, Li Y, et al.
Nutr Metab (Lond)
. 2023 May;
20(1):28.
PMID: 37244987
Non-alcoholic fatty liver disease (NAFLD) is a chronic progressive disease that can progress to non-alcoholic steatohepatitis (NASH). Animal models are important tools for basic NASH research. Immune activation plays a...
9.
Leng J, Tian H, Fang Y, Hu Y, Peng J
Front Cell Infect Microbiol
. 2022 Jul;
12:827516.
PMID: 35865826
Gut-derived lipopolysaccharide (LPS) leaking through the dysfunctional intestinal barrier contributes to the onset of non-alcoholic steatohepatitis (NASH) by triggering inflammation in the liver. In the present study, a combination consisting...
10.
Xiao Y, Li B, Liu J, Wang S, Liu J, Yang H, et al.
Clin Transl Med
. 2022 Apr;
12(4):e691.
PMID: 35474446
Background: Gastric carcinoma (GC) is one of the most deadly diseases due to tumour metastasis and resistance to therapy. Understanding the molecular mechanism of tumour progression and drug resistance will...